Smith B R, Born J L, Garcia D J
Biochem Pharmacol. 1983 May 15;32(10):1609-12. doi: 10.1016/0006-2952(83)90335-0.
The isolated perfused rat liver was evaluated as a model system for the characterization of misonidazole metabolism under hypoxic conditions. Misonidazole metabolism by livers perfused under aerobic conditions was also examined. The clearance of misonidazole was more than three times greater under anaerobic compared to aerobic conditions (4.94 +/- 1.56 vs 1.27 +/- 0.22 ml/min; means +/- S.D., N = 3). Misonidazole metabolites were detected only in the bile. Analysis of these metabolites by reverse-phase high performance liquid chromatography (HPLC) demonstrated that misonidazole metabolism was also qualitatively changed when anaerobic conditions were employed. Misonidazole beta-glucuronide was the major metabolite detected under aerobic conditions, but it was a minor metabolite in anaerobically perfused livers. The three major metabolites produced under anaerobic conditions were not characterized, but desmethyl misonidazole (RO-07-9963) and the 2-amino-imidazole derivative of misonidazole (1-[2-aminoimidazol-1-yl]-3-methoxy-2-propanol) were excluded as possible structures.
将离体灌注大鼠肝脏作为一种模型系统,用于表征低氧条件下米索硝唑的代谢情况。同时也研究了在有氧条件下灌注的肝脏对米索硝唑的代谢。与有氧条件相比,厌氧条件下米索硝唑的清除率高出三倍多(4.94±1.56对1.27±0.22毫升/分钟;均值±标准差,N = 3)。仅在胆汁中检测到米索硝唑代谢物。通过反相高效液相色谱法(HPLC)对这些代谢物进行分析表明,采用厌氧条件时米索硝唑的代谢在定性方面也发生了变化。米索硝唑β-葡萄糖醛酸苷是有氧条件下检测到的主要代谢物,但在厌氧灌注的肝脏中它是次要代谢物。厌氧条件下产生的三种主要代谢物未进行表征,但排除了去甲基米索硝唑(RO-07-9963)和米索硝唑的2-氨基咪唑衍生物(1-[2-氨基咪唑-1-基]-3-甲氧基-2-丙醇)作为可能的结构。